Early activation of myocardial matrix metalloproteinases and degradation of cardiac troponin i after experimental subarachnoid hemorrhage

Journal of Surgical Research

Volumn 179, Issue 1, 2013, Pages

  Lin, Nai Nu ^a,b   Cheng, Ching Chang ^a   Lee, Yen Feng ^a,b   Fu, Yun Ching ^a   Chen, Jiun Sheng ^a,b   Ho, Shu Peng ^b   Chiu, Yung Tsung ^a,b  

^a TAICHUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^b NATIONAL CHUNG HSING UNIVERSITY   (Taiwan)

Author keywords

cTnI degradation; Matrix metalloproteinases; Myocardial dysfunction; Rats; Subarachnoid hemorrhage

Indexed keywords

GELATINASE A; GELATINASE B; MATRIX METALLOPROTEINASE; TROPONIN I;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; ENZYME ACTIVATION; ENZYME ACTIVITY; HEART LEFT VENTRICLE FUNCTION; HOMOGENATE; IMMUNOHISTOCHEMISTRY; INTRACRANIAL PRESSURE; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; RAT; SUBARACHNOID HEMORRHAGE; WESTERN BLOTTING;

ANIMALS; DISEASE MODELS, ANIMAL; INTRACRANIAL PRESSURE; MALE; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MYOCARDIUM; RATS; RATS, SPRAGUE-DAWLEY; SUBARACHNOID HEMORRHAGE; TIME FACTORS; TROPONIN I; VENTRICULAR FUNCTION;

EID: 84870652753     PISSN: 00224804     EISSN: 10958673     Source Type: Journal    
DOI: 10.1016/j.jss.2012.02.008     Document Type: Article

References (26)

1. N.N. Lin, J.S. Kuo, C.C. Cheng, K.C. Tung, F.C. Cheng, and Y.T. Chiu Early cardiac damage after subarachnoid hemorrhage in rats Int J Cardiol 129 2008 433
2. N.M. Banki, A. Kopelnik, M.W. Dae, J. Miss, P. Tung, M.T. Lawton, B.J. Drew, E. Foster, W. Smith, W.W. Parmley, and J.G. Zaroff Acute neurocardiogenic injury after subarachnoid hemorrhage Circulation 112 2005 3314
3. T.B. Horwich, J. Patel, W.R. MacLellan, and G.C. Fonarow Cardiac troponin I is associated with impaired hemodynamics, progressive left ventricular dysfunction, and increased mortality rates in advanced heart failure Circulation 108 2003 833
4. M. Tanabe, E.A. Crago, M.S. Suffoletto, M. Hravnak, J.M. Frangiskakis, A.B. Kassam, M.B. Horowitz, and J. Gorcsan Relation of elevation in cardiac troponin I to clinical severity, cardiac dysfunction, and pulmonary congestion in patients with subarachnoid hemorrhage Am J Cardiol 102 2008 1545
5. A. Schömig Catecholamines in myocardial ischemia. Systemic and cardiac release Circulation 82 1990 II13
6. C. Banfi, V. Cavalca, F. Veglia, M. Brioschi, S. Barcella, L. Mussoni, L. Boccotti, E. Tremoli, P. Biglioli, and P. Agostoni Neurohormonal activation is associated with increased levels of plasma matrix metalloproteinase-2 in human heart failure Eur Heart J 26 2005 481
7. M.L. Coker, M.A. Doscher, C.V. Thomas, Z.S. Galis, and F.G. Spinale Matrix metalloproteinase synthesis and expression in isolated LV myocyte preparations Am J Physiol 277 1999 H777
8. A. Sokal, M. Zembala, A. Radomski, A. Kocher, J. Pacholewicz, J. Los, E. Jedrzejczyk, and M. Radomski A differential release of matrix metalloproteinases 9 and 2 during coronary artery bypass grafting and off-pump coronary artery bypass surgery J Thorac Cardiovasc Surg 137 2009 1218
9. M.M. Lalu, E. Pasini, C.J. Schulze, M. Ferrari-Vivaldi, G. Ferrari-Vivaldi, T. Bachetti, and R. Schulz Ischaemia-reperfusion injury activates matrix metalloproteinases in the human heart Eur Heart J 26 2005 27
10. D. Kelly, G. Cockerill, L.L. Ng, M. Thompson, S. Khan, N.J. Samani, and I.B. Squire Plasma matrix metalloproteinase-9 and left ventricular remodelling after acute myocardial infarction in man: a prospective cohort study Eur Heart J 28 2007 711
11. W. Wang, C.J. Schulze, W.L. Suarez-Pinzon, J.R. Dyck, G. Sawicki, and R. Schulz Intracellular action of matrix metalloproteinase-2 accounts for acute myocardial ischemia and reperfusion injury Circulation 106 2002 1543
12. J.A. Simpson, K.R. Brunt, and S. Iscoe Repeated inspiratory occlusions acutely impair myocardial function in rats J Physiol 586 2008 2345
13. C.C. Cheng, K.C. Tung, Y.C. Fu, C.L. Gong, Y.T. Chen, N.N. Lin, J.A. Lin, and Y.T. Chiu Activated matrix metalloproteinase and disrupted myocardial collagen matrix in increased sympathetic activity following stimulation of dorsal medulla in the vagotomized feline model Chin J Physiol 51 2008 7
14. F.S. Apple, L.A. Pearce, S.W. Smith, J.M. Kaczmarek, and M.M. Murakami Role of monitoring changes in sensitive cardiac troponin I assay results for early diagnosis of myocardial infarction and prediction of risk of adverse events Clin Chem 55 2009 930
15. N.A. Narolska, N. Piroddi, A. Belus, N.M. Boontje, B. Scellini, S. Deppermann, R. Zaremba, R.J. Musters, C. dos Remedios, K. Jaquet, D.B. Foster, A.M. Murphy, J.E. van Eyk, C. Tesi, C. Poggesi, J. van der Velden, and G.J. Stienen Impaired diastolic function after exchange of endogenous troponin I with C-terminal truncated troponin I in human cardiac muscle Circ Res 99 2006 1012
16. V.L. Thijssen, J. Ausma, L. Gorza, H.M. van der Velden, M.A. Allessie, I.C. Van Gelder, M. Borgers, and G.J. van Eys Troponin I isoform expression in human and experimental atrial fibrillation Circulation 110 2004 770
17. S.R. Hall, L. Wang, B. Milne, and M. Hong Left ventricular dysfunction after acute intracranial hypertension is associated with increased hydroxyl free radical production, cardiac ryanodine hyperphosphorylation, and troponin I degradation J Heart Lung Transplant 24 2005 1639
18. X.P. Huang, and J.F. Du Troponin I, cardiac diastolic dysfunction and restrictive cardiomyopathy Acta Pharmacol Sin 25 2004 1569
19. A. Kopelnik, L. Fisher, J.C. Miss, N. Banki, P. Tung, M.T. Lawton, N. Ko, W.S. Smith, B. Drew, E. Foster, and J. Zaroff Prevalence and implications of diastolic dysfunction after subarachnoid hemorrhage Neurocrit Care 3 2005 132
20. I. Massova, L.P. Kotra, R. Fridman, and S. Mobashery Matrix metalloproteinases: structures, evolution, and diversification FASEB J 12 1998 1075
21. G.Y. Wang, M.R. Bergman, A.P. Nguyen, S. Turcato, P.M. Swigart, M.C. Rodrigo, P.C. Simpson, J.S. Karliner, D.H. Lovett, and A.J. Baker Cardiac transgenic matrix metalloproteinase-2 expression directly induces impaired contractility Cardiovasc Res 69 2006 688
22. M.R. Bergman, J.R. Teerlink, R. Mahimkar, L. Li, B.Q. Zhu, A. Nguyen, S. Dahi, J.S. Karliner, and D.H. Lovett Cardiac matrix metalloproteinase-2 expression independently induces marked ventricular remodeling and systolic dysfunction Am J Physiol Heart Circ Physiol 292 2007 H1847
23. K.P. Park, A. Rosell, C. Foerch, C. Xing, W.J. Kim, S. Lee, G. Opdenakker, K.L. Furie, and E.H. Lo Plasma and brain matrix metalloproteinase-9 after acute focal cerebral ischemia in rats Stroke 40 2009 2836
24. Z. Guo, X. Sun, Z. He, Y. Jiang, and X. Zhang Role of matrix metalloproteinase-9 in apoptosis of hippocampal neurons in rats during early brain injury after subarachnoid hemorrhage Neurol Sci 31 2010 143
25. E. Gayat, V. Mor-Avi, L. Weinert, C. Yodwut, and R.M. Lang Noninvasive quantification of left ventricular elastance and ventricular-arterial coupling using three-dimensional echocardiography and arterial tonometry Am J Physiol Heart Circ Physiol 301 2011 H1916
26. G. Opdenakker, P.E. Van den Steen, B. Dubois, I. Nelissen, E. Van Coillie, S. Masure, P. Proost, and J. Van Damme Gelatinase B functions as regulator and effector in leukocyte biology J Leukoc Biol 69 2001 851